Envisagenics is discovering cures
for diseases caused by splicing errors
by integrating AI and RNA therapeutics.
Cancer and genetic diseases affect more than 30 million people
Our mission is to accelerate the development of innovative therapeutics through RNA splicing analysis and artificial intelligence.
15%
of all disease-causing mutations are predicted to disrupt RNA splicing.
370
known genetic disorders in publications are caused by RNA splicing errors.
50%
of synonymous cancer-driver mutations disrupt RNA splicing.
Artificial Intelligence Platform for Drug Discovery
- Investors
- Partners
Sign up for the latest updates
Subscribe to the Envisagenics email newsletter
@envisagenics
© 2018 Envisagenics Inc. All rights reserved.